Skip to main content
Medical information Clinical review pending

Infection Testing

Dengue Virus and Chikungunya Virus RNA Detection Qualitative Test

Detects the presence of Dengue and Chikungunya viruses using Real Time PCR. This test helps diagnose these mosquito-borne viral infections early, guiding appropriate treatment.

General information only: This page is not a diagnosis or personal medical advice. A qualified clinician should decide whether testing is appropriate and interpret results in context.

Review status: No completed medical review is recorded for this page.

Ask a question
Counselor guidance included Confidential handling Kenya-wide coordination

At a glance

Plan your test

Sample
Blood (whole blood, serum, or plasma) or Cerebrospinal Fluid (C.S.F). Confirm specific requirements with the laboratory before booking.
Results
Confirm with the laboratory before booking.
Preparation
No special preparation is required for this test. Patients should inform the laboratory if they are on any medications.
Test priceKSh 8,500

Payment: M-Pesa and card options can be confirmed during booking.

Insurance & government schemes

Is this test covered for you?

We help you verify whether the Dengue Virus and Chikungunya Virus RNA Detection Qualitative Test test can be claimed against your insurer, employer scheme or a Kenyan government health scheme — before you book. Coverage depends on your plan, clinical indication and your provider's rules; final approval always rests with them.

Talk to a claims advisor

Providers & schemes we can help you check

Government & public schemes

SHIF — Social Health Insurance Fund Linda Mama EduAfya NHIF (legacy cards)

Eligibility and benefits follow the current rules of the Social Health Authority (SHA) and applicable government programmes.

Private insurers & employer schemes

Jubilee Health AAR APA Britam CIC Madison Resolution Pioneer Minet Old Mutual GA Life Heritage + other licensed insurers

Names shown for identification only — listing does not imply partnership or guarantee of coverage.

Have these ready when we check

  • Insurer or scheme name & policy / member number
  • A clinician's request / prescription for the test
  • Pre-authorisation letter, if your plan requires one

Free coverage check

Ask us to verify your cover

Send your details and our claims team confirms what documents you need and whether pre-authorisation applies — usually the same working day.

+254

Used only to process your coverage check — see our Privacy Policy. Verification support is free and does not guarantee your provider will pay.

01

Start with fit

Is this the right test for you?

The best test starts with a clear clinical question. These are common reasons a clinician or family may consider this test.

  • ✓Symptoms suggestive of Dengue fever (e.g., high fever, severe headache, joint/muscle pain, rash).
  • ✓Symptoms suggestive of Chikungunya fever (e.g., abrupt onset fever, severe joint pain).
  • ✓Recent travel to or residence in areas with known Dengue or Chikungunya outbreaks.
  • ✓Differential diagnosis of febrile illness.
  • ✓Monitoring for potential complications in suspected cases.
02

In plain language

What this test helps you understand

This test is used to confirm or rule out active Dengue or Chikungunya virus infection, aiding in clinical diagnosis and management.
The Dengue Virus and Chikungunya Virus RNA Detection Qualitative Test is a diagnostic tool used to identify the presence of RNA from the Dengue and Chikungunya viruses in patients. These viruses are spread through mosquito bites and can cause significant health issues if not diagnosed promptly. This test is particularly relevant in areas like Kenya where these viruses are common.

This test uses Real Time PCR technology to detect the viral RNA in blood, serum, plasma, or cerebrospinal fluid (C.S.F) samples. It provides a qualitative result, meaning it indicates whether the viruses are present or not.

Early diagnosis is crucial for managing these infections effectively and preventing complications. This test helps healthcare providers make informed decisions about patient care.
03

Medical review status

Clinical review pending

A completed medical review is not recorded for this page. No clinician has endorsed the information shown here. Please discuss testing decisions with a qualified healthcare professional.

Meet the DNA Labs Kenya medical team →
04

A simple process

What happens next?

You do not have to navigate the test alone. We help you move from question to next step.

1

Speak with us

We check the test and answer your questions before collection.

2

Give your sample

Choose home collection or a coordinated hub visit in Kenya. We explain whether this test uses a cheek swab or blood draw.

3

Understand your report

A counselor helps you understand the result and the next steps.

05

Choose your collection

Home collection or a lab visit

We will explain the sample, preparation, and next steps before anything is collected.

Home collection

Choose a coordinated visit at home or another convenient location. Our team confirms the appointment and sample requirements in advance.

Lab or hub visit

Prefer to visit a coordinated location? We can guide you to the right hub and explain what to expect when you arrive.

Ask about locations →
PreparationNo special preparation is required for this test. Patients should inform the laboratory if they are on any medications.
SampleBlood (whole blood, serum, or plasma) or Cerebrospinal Fluid (C.S.F). Confirm specific requirements with the laboratory before booking.
MethodologyReal Time Polymerase Chain Reaction (PCR).
PrivacyYour sample and report are handled confidentially. Ask the team how your information is stored and shared.
This test detects viral RNA, which may be present only during the early stages of infection. A negative result does not completely rule out infection, especially if the sample is collected later in the illness. Cross-reactivity with other flaviviruses is possible, though rare.
06

Read your report

What common result terms mean

PositiveA finding was identified. Your clinician or counselor will explain what it means for your care.
NegativeThe specific finding tested for was not identified. It does not rule out every possible cause.
VUSA variant was found, but current evidence is not enough to classify it. Your counselor can explain follow-up.
07

Questions people ask

Frequently asked questions

Dengue and Chikungunya are viral infections transmitted by mosquitoes. They can cause symptoms like fever, joint pain, rash, and fatigue.
Early diagnosis allows for appropriate medical care, monitoring for complications, and helps prevent further spread of the infection.
A blood sample (whole blood, serum, or plasma) or cerebrospinal fluid (C.S.F) is typically required. Please confirm the exact requirement with the lab.
Results are typically available within a specified timeframe. Confirm delivery method (e.g., email, phone) and timeframe with the laboratory.
Insurance coverage varies. Please check with your insurance provider regarding coverage for this specific test.
08

Collaboration

Open for partnership with hospitals, clinics, doctors & researchers

Whether you are referring patients, building a research programme or supporting students, we work as an extension of your team — with responsive communication and clear scientific standards.

Hospitals & clinics

Referral pathways, coordinated sample logistics and shared reporting that fits your clinical workflow.

Doctors & specialists

LOINC-coded reports, ACMG-based variant classification and a direct scientific line for complex cases.

Research institutions

Sanger sequencing, NGS panels and custom assays — with project design support, batch pricing and agreed turnaround commitments.

Students & academic projects

Discounted laboratory services for college, master's and PhD research projects — including proposal guidance and cost-effective batch testing.

Explore partnerships
09

Trust & transparency

Sources, standards & how this page is maintained

Standards & references

  • ACMG/AMP technical standards for sequence variant interpretation
  • ClinGen curation and gene–disease validity frameworks where applicable
  • LOINC-coded reporting for interoperable results
  • ISO 9001:2015 quality management; ISO 15189 accreditation in progress

Page provenance

  • Last updated: September 27, 2026
  • Medical review: not yet completed
  • Written for patients & clinicians in Kenya; reviewed periodically against current guidance

Medical disclaimer: this page is general information, not a diagnosis or personal medical advice. Testing decisions and result interpretation should be made with a qualified healthcare professional.

Keep exploring

Related tests

View all tests →
Chat on WhatsApp